IL134199A0 - MEDICAMENTS CONTAINING 5α-ANDROST-1-ENE-17β-CARBOXAMIDE DERIVATIVES - Google Patents

MEDICAMENTS CONTAINING 5α-ANDROST-1-ENE-17β-CARBOXAMIDE DERIVATIVES

Info

Publication number
IL134199A0
IL134199A0 IL13419998A IL13419998A IL134199A0 IL 134199 A0 IL134199 A0 IL 134199A0 IL 13419998 A IL13419998 A IL 13419998A IL 13419998 A IL13419998 A IL 13419998A IL 134199 A0 IL134199 A0 IL 134199A0
Authority
IL
Israel
Prior art keywords
androst
ene
carboxamide derivatives
medicaments containing
seborrhea
Prior art date
Application number
IL13419998A
Other languages
English (en)
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of IL134199A0 publication Critical patent/IL134199A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
IL13419998A 1997-07-29 1998-07-27 MEDICAMENTS CONTAINING 5α-ANDROST-1-ENE-17β-CARBOXAMIDE DERIVATIVES IL134199A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20313697 1997-07-29
PCT/JP1998/003337 WO1999006050A1 (en) 1997-07-29 1998-07-27 Remedial agent for baldness and other diseases

Publications (1)

Publication Number Publication Date
IL134199A0 true IL134199A0 (en) 2001-04-30

Family

ID=16469018

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13419998A IL134199A0 (en) 1997-07-29 1998-07-27 MEDICAMENTS CONTAINING 5α-ANDROST-1-ENE-17β-CARBOXAMIDE DERIVATIVES

Country Status (21)

Country Link
US (1) US6380179B1 (de)
EP (1) EP0998930B1 (de)
KR (1) KR20010022066A (de)
CN (1) CN1129433C (de)
AT (1) ATE262337T1 (de)
AU (1) AU733830B2 (de)
BR (1) BR9811293A (de)
CA (1) CA2298851A1 (de)
DE (1) DE69822636T2 (de)
DK (1) DK0998930T3 (de)
ES (1) ES2218840T3 (de)
HU (1) HUP0003159A3 (de)
ID (1) ID24566A (de)
IL (1) IL134199A0 (de)
NO (1) NO20000469L (de)
NZ (1) NZ502537A (de)
PL (1) PL338414A1 (de)
PT (1) PT998930E (de)
RU (1) RU2193887C2 (de)
TR (1) TR200000263T2 (de)
WO (1) WO1999006050A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT963998E (pt) * 1997-02-26 2004-07-30 Sankyo Co Composicoes para tratar ou prevenir cancro prostatico
US20050169870A1 (en) * 2004-02-02 2005-08-04 Schering Corporation Methods of modulating CD200
CN103127111B (zh) * 2005-06-24 2016-02-10 代表亚利桑那大学的亚利桑那校董会 用于治疗头发生长病症比如女性型脱发的方法及可用于此的组合物
US20080108681A1 (en) * 2006-10-27 2008-05-08 Access Business Group International Llc Use of allantoin as a pro-collagen synthesis agent in cosmetic compositions
WO2011014649A1 (en) 2009-07-29 2011-02-03 Duke University Compositions and methods for inhibiting hair growth
MX2010012945A (es) * 2010-11-24 2012-05-24 Fidel Ojeda Gomez Una formula para el control y eliminacion de seborrea y alopecia en el cuero cabelludo.
RU2477155C2 (ru) * 2011-04-27 2013-03-10 Закрытое акционерное общество "Патент-Фарм" Способ лечения андрогенетической алопеции

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571817A (en) 1984-02-27 1996-11-05 Merck & Co., Inc. Methods of treating androgenic alopecia with finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones]
US5516768A (en) 1990-03-16 1996-05-14 Smithkline Beecham Corporation Uncompetitive inhibition of steroid and 5α-reductose
IE76452B1 (en) * 1990-10-29 1997-10-22 Sankyo Co Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use
JP3030152B2 (ja) * 1992-02-03 2000-04-10 三共株式会社 ４−アザステロイド化合物
US5278159A (en) * 1992-10-06 1994-01-11 Merck & Co., Inc. Aryl ester derivatives of 3-oxo-4-aza-androstane 17-β-carboxylates as 5-α-reductase inhibitors
US5486511A (en) * 1993-05-25 1996-01-23 Merrell Dow Pharmaceuticals Inc. 4-amino-17β-(cyclopropyloxy)androst-4-en-3-one, 4-amino-17β-(cyclopropylamino)androst-4-en-3-one and related compounds as C17-20 lyase and 5α-reductase
TW382595B (en) 1993-10-15 2000-02-21 Merck & Co Inc Pharmaceutical composition for use in arresting and reversing androgenic alopecia
JPH0873492A (ja) * 1994-06-28 1996-03-19 Sankyo Co Ltd アザステロイド類
US5635197A (en) 1995-03-21 1997-06-03 Eli Lilly And Company Treatment and prevention of prostatic cancer metastasis
US5629007A (en) 1995-03-21 1997-05-13 Eli Lilly And Company Method of preventing prostatic cancer development
AU7078296A (en) 1995-09-27 1997-04-17 Merck & Co., Inc. Method of preventing androgenetic alopecia with 5-alpha reductase inhibitors
PT923942E (pt) * 1996-02-05 2002-03-28 Sankyo Co Preparacao inibidora de 5alfa-reductase para administracao oral um processo para producao da mesma e sua utilizacao
PT963998E (pt) * 1997-02-26 2004-07-30 Sankyo Co Composicoes para tratar ou prevenir cancro prostatico
US6093722A (en) 1997-02-26 2000-07-25 Sankyo Company, Limited Method for treating prostate cancer

Also Published As

Publication number Publication date
DE69822636T2 (de) 2005-01-05
EP0998930B1 (de) 2004-03-24
HUP0003159A2 (hu) 2001-04-28
RU2193887C2 (ru) 2002-12-10
HUP0003159A3 (en) 2001-07-30
DK0998930T3 (da) 2004-04-26
AU733830B2 (en) 2001-05-24
TR200000263T2 (tr) 2000-09-21
CA2298851A1 (en) 1999-02-11
US6380179B1 (en) 2002-04-30
AU8358598A (en) 1999-02-22
CN1129433C (zh) 2003-12-03
NO20000469D0 (no) 2000-01-28
DE69822636D1 (de) 2004-04-29
WO1999006050A1 (en) 1999-02-11
HK1027290A1 (en) 2001-01-12
ATE262337T1 (de) 2004-04-15
NZ502537A (en) 2002-11-26
BR9811293A (pt) 2000-08-29
PL338414A1 (en) 2000-11-06
ID24566A (id) 2000-07-27
EP0998930A1 (de) 2000-05-10
ES2218840T3 (es) 2004-11-16
KR20010022066A (ko) 2001-03-15
PT998930E (pt) 2004-05-31
EP0998930A4 (de) 2002-06-12
CN1271285A (zh) 2000-10-25
NO20000469L (no) 2000-03-28

Similar Documents

Publication Publication Date Title
MY119150A (en) Azetidine derivatives, their preparation and medicaments containing them
AU3744397A (en) Total synthesis of antitumor acylfulvenes
MX9800718A (es) Derivados de 2-(4-substituidos)-bencilamino-2-metil- propanamida.
BG104569A (en) Substituted 2-benzylamino-2-phenyl-acetamide compounds
AU618506B2 (en) Suppression of parathyroid hormone synthesis and secretion
GR3035664T3 (en) Novel terphenyl compounds and medicines containing the same
MX9805023A (es) Derivados de 1-metilcarbapenem.
IL134199A0 (en) MEDICAMENTS CONTAINING 5α-ANDROST-1-ENE-17β-CARBOXAMIDE DERIVATIVES
AU7872798A (en) 16-ene-vitamin D derivatives
EP0826684A4 (de) Piperidinderivate
AU681021B2 (en) Indole derivative and medicine containing the same
NO994107D0 (no) Preparater for behandling eller forhindring av prostatakreft
AU2025295A (en) 7-Glycosyloxybenzopyran derivative and antiallergic agent containing the derivative as active ingredient
AU7649796A (en) Compound gexi
CA2245484A1 (en) Novel urea derivatives
HUT75124A (en) Use of bicyclolactam derivatives for producing pharmaceutical compositions having anxiolytic activity
EP0997457A4 (de) 3-benzoylindol-derivate und sie enthaltende medikamente
GR3004321T3 (de)
EP0609457A4 (en) Benzene derivative.
AU6943796A (en) Compounds UCH 15